UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Ability of recombinant interferon gamma in vitro to restore the defective polymorphonuclear-cell- but not lymphocyte-mediated cytotoxic activities in patients with myelodysplastic syndromes

Cancer Immunology, Immunotherapy, 1992-11, Vol.34 (6), p.414-418

1992

Volltextzugriff (PDF)

Ability of recombinant interferon γ in vitro to restore the polymorphonuclear-cell- but not lymphocyte-mediated cytotoxic activities in patients with myelodysplastic syndromes

Cancer immunology and immunotherapy, 1992, Vol.34 (6), p.414-418

1992

Volltextzugriff (PDF)

Abstract 3912: The PI3K/mTOR dual inhibitor PF-04691502 shows antitumor activity in Sezary cells and in a xenograft mouse model

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.3912-3912

2019

Volltextzugriff (PDF)

Abstract 761: The role of PI3 kinase pathway in the the skin of Sezary syndrome

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.761-761

2018

Volltextzugriff (PDF)

Antipruritic effect of oral cyclosporin A in essential senile pruritus

Acta dermato-venereologica, 1998-05, Vol.78 (3), p.232-232

1998

Volltextzugriff (PDF)

Blood and skin-derived Sezary cells: differences in proliferation-index, activation of PI3K/AKT/mTORC1 pathway and its prognostic relevance

Leukemia, 2019-05, Vol.33 (5), p.1231-1242

2019

Volltextzugriff (PDF)

The CD40/CD40 ligand system is expressed in the cutaneous lesions of erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis spectrum: CD40/CD40L in EM and SJS/TEN

British journal of dermatology (1951), 2006-02, Vol.154 (2), p.319-324

2006

Volltextzugriff (PDF)

The CD40/CD40 ligand system is expressed in the cutaneous lesions of erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis spectrum

British journal of dermatology (1951), 2006-02, Vol.154 (2), p.319-324

2006

Volltextzugriff (PDF)

Chronic venous hypertension: Immunological alterations as possible pathomechanism for leg ulcers

Journal of the European Academy of Dermatology and Venereology, 1998-09, Vol.11, p.S161-S161

1998

Volltextzugriff (PDF)

Circulating Interleukin 16 (IL‐16) in children with atopic/eczema dermatitis syndrome (AEDS): a novel serological marker of disease activity

Allergy (Copenhagen), 2002-09, Vol.57 (9), p.815-820

2002

Volltextzugriff (PDF)

CLINICAL AND LABORATORY INVESTIGATIONS: Expression of cytokines and chemokine receptors in the cutaneous lesions of erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis

British journal of dermatology (1951), 2006-10, Vol.155 (4), p.722-728

2006

Volltextzugriff (PDF)

Clinical efficacy and modification of erythema index, hydration and skin barrier function in seborrheic dermatitis by antinflammatory cream containing furalglucytol

Journal of the European Academy of Dermatology and Venereology, 1998-09, Vol.11, p.S262-S262

1998

Volltextzugriff (PDF)

Cyclosporin A (CyA) reduces sCD30 serum levels in atopic dermatitis: a possible new immune intervention

Allergy (Copenhagen), 1999-05, Vol.54 (5), p.507-510

1999

Volltextzugriff (PDF)

Cyclosporine is able to reduce sCD30 serum levels in atopic dermatitis

Journal of the European Academy of Dermatology and Venereology, 1998-09, Vol.11, p.S199-S199

1998

Volltextzugriff (PDF)

Cytokine and chemokine levels in systemic sclerosis: relationship with cutaneous and internal organ involvement

Clinical and experimental immunology, 2004-12, Vol.138 (3), p.540-546

2004

Volltextzugriff (PDF)

Distinct delayed T‐cell response to β‐methasone and penicillin‐G in the same patient

Allergy (Copenhagen), 2003-05, Vol.58 (5), p.439-444

2003

Volltextzugriff (PDF)

Eotaxins and CCR3 receptor in inflammatory and allergic skin diseases: therapeutical implications

Current drug targets. Inflammation & allergy, 2003-03, Vol.2 (1), p.81-94

2003

Volltextzugriff (PDF)

Evaluation of inflammatory parameters in physical urticarias and effects of an anti-inflammatory/antiallergic treatment

International journal of dermatology, 2002-07, Vol.41 (7), p.431-438

2002

Volltextzugriff (PDF)

Expression of cytokines and chemokine receptors in the cutaneous lesions of erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis

British journal of dermatology (1951), 2006-10, Vol.155 (4), p.722-728

2006

Volltextzugriff (PDF)

Expression of cytokines and chemokine receptors in the cutaneous lesions of erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis: Cytokines and chemokine receptors in EM and SJS/TEN

British journal of dermatology (1951), 2006-10, Vol.155 (4), p.722-728

2006

Volltextzugriff (PDF)

Expression of matrix metalloproteinases 2, 9 and 11 in erythema multiforme: immunohistochemical comparison with Stevens-Johnson syndrome/toxic epidermal necrolysis

British journal of dermatology (1951), 2008-05, Vol.158 (5), p.1163-1166

2008

Volltextzugriff (PDF)

FC002 Th2 involvement in the pathogenesis of bullous pemphigoid

Journal of the European Academy of Dermatology and Venereology, 1997-09, Vol.9, p.S115-S115

1997

Volltextzugriff (PDF)

Immunohistochemical Expression of Apoptotic Markers in Drug-Induced Erythema Multiforme, Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis

International journal of immunopathology and pharmacology, 2007-07, Vol.20 (3), p.557-566

2007

Volltextzugriff (PDF)

Increased expression of eotaxin and its specific receptor CCR3 in bullous pemphigoid

EJD. European journal of dermatology, 2002, Vol.12 (1), p.27-31

2002

Volltextzugriff (PDF)

Increased IL-18 in patients with systemic lupus erythematosus: relations with Th-1, Th-2, pro-inflammatory cytokines and disease activity. IL-18 is a marker of disease activity but does not correlate with pro-inflammatory cytokines

Clinical and experimental rheumatology, 2002-07, Vol.20 (4), p.535

2002

Volltextzugriff (PDF)

1 – 25 von 65

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(59)
Mit Volltextzugriff
(52)

Publikationsform

Artikel
(65)

Sprache

Englisch
(63)
Italienisch
(2)

Erscheinungsjahr

n.n

Thema

Humans
(38)
Science & Technology
(33)
Life Sciences & Biomedicine
(32)
Male
(25)
Biological And Medical Sciences
(23)
Medical Sciences
(23)
Female
(22)
Dermatology
(21)
Middle Aged
(20)
Adult
(18)
Immunology
(12)
Aged
(11)
Bullous Diseases Of The Skin
(8)
Immunopathology
(8)
Allergic Diseases
(6)
Allergy
(6)
Erythema Multiforme
(6)
Skin Allergic Diseases. Stinging Insect Allergies
(6)
Adolescent
(5)
Aged, 80 And Over
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Ability of recombinant interferon gamma in vitro to restore the defective polymorphonuclear-cell- but not lymphocyte-mediated cytotoxic activities in patients with myelodysplastic syndromes

Ability of recombinant interferon γ in vitro to restore the polymorphonuclear-cell- but not lymphocyte-mediated cytotoxic activities in patients with myelodysplastic syndromes

Abstract 3912: The PI3K/mTOR dual inhibitor PF-04691502 shows antitumor activity in Sezary cells and in a xenograft mouse model

Abstract 761: The role of PI3 kinase pathway in the the skin of Sezary syndrome

Antipruritic effect of oral cyclosporin A in essential senile pruritus

Blood and skin-derived Sezary cells: differences in proliferation-index, activation of PI3K/AKT/mTORC1 pathway and its prognostic relevance

The CD40/CD40 ligand system is expressed in the cutaneous lesions of erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis spectrum: CD40/CD40L in EM and SJS/TEN

The CD40/CD40 ligand system is expressed in the cutaneous lesions of erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis spectrum

Chronic venous hypertension: Immunological alterations as possible pathomechanism for leg ulcers

Circulating Interleukin 16 (IL‐16) in children with atopic/eczema dermatitis syndrome (AEDS): a novel serological marker of disease activity

CLINICAL AND LABORATORY INVESTIGATIONS: Expression of cytokines and chemokine receptors in the cutaneous lesions of erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis

Clinical efficacy and modification of erythema index, hydration and skin barrier function in seborrheic dermatitis by antinflammatory cream containing furalglucytol

Cyclosporin A (CyA) reduces sCD30 serum levels in atopic dermatitis: a possible new immune intervention

Cyclosporine is able to reduce sCD30 serum levels in atopic dermatitis

Cytokine and chemokine levels in systemic sclerosis: relationship with cutaneous and internal organ involvement

Distinct delayed T‐cell response to β‐methasone and penicillin‐G in the same patient

Eotaxins and CCR3 receptor in inflammatory and allergic skin diseases: therapeutical implications

Evaluation of inflammatory parameters in physical urticarias and effects of an anti-inflammatory/antiallergic treatment

Expression of cytokines and chemokine receptors in the cutaneous lesions of erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis

Expression of cytokines and chemokine receptors in the cutaneous lesions of erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis: Cytokines and chemokine receptors in EM and SJS/TEN

Expression of matrix metalloproteinases 2, 9 and 11 in erythema multiforme: immunohistochemical comparison with Stevens-Johnson syndrome/toxic epidermal necrolysis

FC002 Th2 involvement in the pathogenesis of bullous pemphigoid

Immunohistochemical Expression of Apoptotic Markers in Drug-Induced Erythema Multiforme, Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis

Increased expression of eotaxin and its specific receptor CCR3 in bullous pemphigoid

Increased IL-18 in patients with systemic lupus erythematosus: relations with Th-1, Th-2, pro-inflammatory cytokines and disease activity. IL-18 is a marker of disease activity but does not correlate with pro-inflammatory cytokines

Suchergebnisse filtern